CA2695076A1 - Process for the preparation of alfuzosin hydrochloride - Google Patents

Process for the preparation of alfuzosin hydrochloride Download PDF

Info

Publication number
CA2695076A1
CA2695076A1 CA2695076A CA2695076A CA2695076A1 CA 2695076 A1 CA2695076 A1 CA 2695076A1 CA 2695076 A CA2695076 A CA 2695076A CA 2695076 A CA2695076 A CA 2695076A CA 2695076 A1 CA2695076 A1 CA 2695076A1
Authority
CA
Canada
Prior art keywords
process according
alfuzosin
acid
amino
dimethoxyquinazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2695076A
Other languages
English (en)
French (fr)
Inventor
Rajendra Narayanrao Kankan
Dharmaraj Ramachandra Rao
Dilip Birari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2695076A1 publication Critical patent/CA2695076A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA2695076A 2007-08-02 2008-08-01 Process for the preparation of alfuzosin hydrochloride Abandoned CA2695076A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1493/MUM/2007 2007-08-02
IN1493MU2007 2007-08-02
PCT/GB2008/002632 WO2009016387A2 (en) 2007-08-02 2008-08-01 Process for the preparation of alfuzosin hydrochloride

Publications (1)

Publication Number Publication Date
CA2695076A1 true CA2695076A1 (en) 2009-02-05

Family

ID=40304963

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2695076A Abandoned CA2695076A1 (en) 2007-08-02 2008-08-01 Process for the preparation of alfuzosin hydrochloride

Country Status (9)

Country Link
US (1) US8716476B2 (enExample)
EP (1) EP2178864B1 (enExample)
JP (1) JP2010535185A (enExample)
KR (1) KR20100044239A (enExample)
AU (1) AU2008281567B2 (enExample)
CA (1) CA2695076A1 (enExample)
NZ (1) NZ582950A (enExample)
WO (1) WO2009016387A2 (enExample)
ZA (1) ZA201000802B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2178864B1 (en) 2007-08-02 2014-07-23 Cipla Limited Process for the preparation of alfuzosin hydrochloride
CN104893626B (zh) 2010-03-09 2017-08-08 汉高知识产权控股有限责任公司 用于压敏粘合剂的阳离子的可uv交联的丙烯酸聚合物
AR107672A1 (es) * 2016-02-22 2018-05-23 Hoffmann La Roche Proceso para la fabricación de derivados de 3-piperazin-1-il-propilamina
CN113801069B (zh) * 2020-06-15 2024-03-15 鲁南制药集团股份有限公司 一种盐酸阿夫唑嗪中间体化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2421888A1 (fr) * 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
YU70890A (en) 1989-04-21 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for obtaining quinazoline derivatives
JPH07206857A (ja) 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
WO2006090268A2 (en) * 2005-02-28 2006-08-31 Glenmark Pharmaceuticals Limited Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin
US20070066824A1 (en) 2005-09-22 2007-03-22 Anumula Raghupathi R Preparation of alfuzosin
US20070105880A1 (en) * 2005-11-08 2007-05-10 Torrent Pharmaceuticals Limited Process for the preparation of alfuzosin
EP1968970A2 (en) * 2005-12-16 2008-09-17 Wockhardt Limited Processes for the preparation of alfuzosin
WO2007074364A1 (en) * 2005-12-26 2007-07-05 Aurobindo Pharma Limited Process for the preparation of alfuzosin
WO2008114272A2 (en) * 2007-03-22 2008-09-25 Cadila Healthcare Limited Process for preparing alpuzosin and crystalline alfuzosin hydrochloride
EP2178864B1 (en) 2007-08-02 2014-07-23 Cipla Limited Process for the preparation of alfuzosin hydrochloride

Also Published As

Publication number Publication date
WO2009016387A2 (en) 2009-02-05
EP2178864A2 (en) 2010-04-28
JP2010535185A (ja) 2010-11-18
KR20100044239A (ko) 2010-04-29
NZ582950A (en) 2011-06-30
EP2178864B1 (en) 2014-07-23
ZA201000802B (en) 2010-12-29
US8716476B2 (en) 2014-05-06
AU2008281567A1 (en) 2009-02-05
US20100256370A1 (en) 2010-10-07
WO2009016387A3 (en) 2009-07-02
AU2008281567B2 (en) 2012-07-26

Similar Documents

Publication Publication Date Title
CN106866553B (zh) 一种法匹拉韦的合成方法
US10421717B2 (en) Process for preparing brivaracetam
US5756736A (en) Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US9216943B2 (en) Preparation of fingolimod and its salts
US20150038727A1 (en) Method for preparing silodosin
CA2695076A1 (en) Process for the preparation of alfuzosin hydrochloride
US20120108809A1 (en) Process for preparation of efavirenz
US7741507B2 (en) Process for preparing Valsartan
US6730809B2 (en) Processes for the production of α-difluoromethyl ornithine (DFMO)
WO2018032555A1 (zh) 二氢异吲哚衍生物及其类似物的制备方法
EP2714691B1 (en) Process for the preparation of 2-amino-9-((2-phenyl-1,3-dioxan-5-yloxy)methyl)-1h-purin-6(9h)-one compound useful in the preparation of valganciclovir
US12060384B2 (en) Synthesis of 1,2,5-tri-o-benzoyl-3-dibenzylamino-3-deoxyribose as intermediate for producing 3′-amino-3′-deoxyadenosine and 3′-amino-3′-deoxyguanosine and the protected derivatives thereof
WO2012056468A1 (en) A process for the preparation of bosentan
EP2702045B1 (en) Novel process for the preparation of etravirine
CN111560021B (zh) 一种德高替尼中间体及其制备方法
JP4356111B2 (ja) Ｎ−（２−アミノ−１，２−ジシアノビニル）ホルムアミジンの製造方法
US20090312351A1 (en) Processes for the Preparation of Alfuzosin
WO2017081701A1 (en) An improved process for the preparation of thalidomide
CN116751193B (zh) 一种通过Mitsunobu缩合法合成恩曲他滨的方法
JP2003509504A (ja) リトナビルの合成方法
JP7617845B2 (ja) （６Ｓ）－３－［（４Ｓ）－４－シアノ－２－オキソ－ピロリジン－１－イル］－６－メチル－Ｎ－（３，４，５－トリフルオロフェニル）－６，７－ジヒドロ－４Ｈ－ピラゾロ［１，５－ａ］ピラジン－５－カルボキサミドの調製のための方法
WO2025173029A1 (en) An improved process for the preparation of deucravacitinib
WO2024064745A1 (en) Synthesis of reldesemtiv
AU2017409559B2 (en) An improved process for the preparation of N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy) quinazolin -4-amine dihydrochloride
HK40059073A (en) Process for the preparation of (6s)-3-[(4s)-4-cyano-2-oxo-pyrrolidin-1-yl]-6-methyl-n-(3,4,5-trifluorophenyl)-6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine-5-carboxamide

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20140801